Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart

Hiroyuki Nishi1, Toshiki Takahashi, Hajime Ichikawa

  • 1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. nishi24@jc4.so-net.ne.jp

Insights

Preoperative liver function tests, including total bilirubin (T-bil) and albumin (Alb), can predict postoperative liver dysfunction in severe valvular disease patients. Cholinesterase (ChE) also predicts mortality, leading to a new prognostic liver score.

Area of Science:

  • Cardiology
  • Hepatology
  • Surgical Oncology

Background:

  • Chronic congestive liver dysfunction is a significant comorbidity in patients undergoing open-heart surgery for advanced valvular disease.
  • Accurate preoperative assessment of liver function is crucial for predicting outcomes in these high-risk patients.

Purpose of the Study:

  • To explore the prognostic value of preoperative liver function tests in patients with severe valvular disease and associated congestive liver dysfunction.
  • To identify key indicators for predicting postoperative liver dysfunction and mortality.

Main Methods:

  • A cohort of 63 patients with valvular disease and moderate to severe tricuspid regurgitation were studied between 1997 and 2004.
  • Preoperative assessments included indocyanine green retention rate at 15 min (ICG15), Child-Pugh score, serum total bilirubin (T-bil), aspartate aminotransferase (AST), alanine aminotransferase (ALT), cholinesterase (ChE), albumin (Alb), and prothrombin time.
  • These factors were compared with postoperative liver dysfunction and mortality, and a new liver function score was developed.

Main Results:

  • Eight in-hospital deaths (13%) and 17 cases of postoperative liver dysfunction were observed.
  • Univariate analysis showed significant differences in preoperative T-bil, Alb, ChE, ICG15, and Child-Pugh score between patients with and without liver dysfunction.
  • Multivariate analysis identified preoperative T-bil as a significant predictor of postoperative liver dysfunction and preoperative ChE as a predictor of mortality.

Conclusions:

  • Preoperative serum total bilirubin (T-bil) and albumin (Alb) levels are valuable for prognosticating postoperative liver dysfunction in severe valvular disease.
  • Preoperative cholinesterase (ChE) is a significant predictor of mortality.
  • A novel liver function score incorporating T-bil, ChE, and Alb is proposed for predicting postoperative hepatic dysfunction and patient outcomes.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...